Characterization and identification of PARM-1 as a new potential oncogene

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Charfi, Cyndia ^a   Levros, Louis Charles ^a   Edouard, Elsy ^a   Rassart, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Gene profiling; Graffi MuLV; Oncogene; PARM 1; T leukemia

Indexed keywords

ALPHA TUBULIN; CAVEOLIN 1; COMPLEMENTARY DNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN; PROSTATE ANDROGEN REGULATED MUCIN LIKE PROTEIN 1; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DELETION MUTANT; DISEASE ASSOCIATION; ENDOSOME; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GOLGI COMPLEX; HUMAN; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; TRANSIENT TRANSFECTION;

ANDROGEN-BINDING PROTEIN; ANIMALS; CAVEOLIN 1; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENDOSOMES; GENE EXPRESSION; GENE EXPRESSION PROFILING; GOLGI APPARATUS; HUMANS; LEUKEMIA, T-CELL; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; NIH 3T3 CELLS; ONCOGENES; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUBULIN;

MURINAE;

EID: 84880893729     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-84     Document Type: Article

References (45)

1. Voisin V, Barat C, Hoang T, Rassart E. Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus. J Virol 2006, 80:4026-4037. 10.1128/JVI.80.8.4026-4037.2006, 1440465, 16571819.
2. Voisin V, Legault P, Ospina DP, Ben-David Y, Rassart E. Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus. BMC Med Genomics 2010, 3:2. 10.1186/1755-8794-3-2, 2843641, 20102610.
3. Charfi C, Voisin V, Levros LC, Edouard E, Rassart E. Gene profiling of Graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene. Blood 2011, 117:1899-1910. 10.1182/blood-2010-10-311001, 21135260.
4. Lymphoid leukemias induced by the murine retrovirus Graffi http://www.biomed.uqam.ca/rassart/microarray2.html.
5. Arima N, Matsushita K, Suruga Y, Ohtsubo H, Fujiwara H, Hidaka S, Arimura K, Kukita T, Yamaguchi K, Fukumori J, Tanaka H. IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. Leuk Res 1998, 22:265-273. 10.1016/S0145-2126(97)00168-9, 9619918.
6. Yang J, Liu X, Nyland SB, Zhang R, Ryland LK, Broeg K, Baab KT, Jarbadan NR, Irby R, Loughran TP. Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood 2010, 115:51-60. 10.1182/blood-2009-06-223719, 2803691, 19880494.
7. Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL, Kurtin PJ, Dogan A. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009, 23:574-580. 10.1038/leu.2008.320, 2656414, 18987657.
8. Khwaja SS, Liu H, Tong C, Jin F, Pear WS, van Deursen J, Bram RJ. HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice. J Clin Invest 2010, 120:2537-2548. 10.1172/JCI41277, 2898592, 20516639.
9. Yen CH, Lu YC, Li CH, Lee CM, Chen CY, Cheng MY, Huang SF, Chen KF, Cheng AL, Liao LY, et al. Functional Characterization of Glycine N-methyltransferase and its Interactive Protein-DEPDC6/DEPTOR in Hepatocellular Carcinoma. Mol Med 2011, 18:286-296.
10. Lee DJ, Schonleben F, Banuchi VE, Qiu W, Close LG, Assaad AM, Su GH. Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis. Cancer Biol Ther 2010, 10:689-693. 10.4161/cbt.10.7.12886, 3093810, 20657180.
11. Dayyani F, Wang J, Yeh JR, Ahn EY, Tobey E, Zhang DE, Bernstein ID, Peterson RT, Sweetser DA. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 2008, 111:4338-4347. 10.1182/blood-2007-07-103291, 2288729, 18258796.
12. Katz RL, He W, Khanna A, Fernandez RL, Zaidi TM, Krebs M, Caraway NP, Zhang HZ, Jiang F, Spitz MR, et al. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 2010, 16:3976-3987. 10.1158/1078-0432.CCR-09-3358, 2949278, 20651054.
13. Devine PL, McKenzie IF. Mucins: structure, function, and associations with malignancy. Bioessays 1992, 14:619-625. 10.1002/bies.950140909, 1365918.
14. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004, 4:45-60. 10.1038/nrc1251, 14681689.
15. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011, 8:785-786. 10.1038/nmeth.1701, 21959131.
16. Julenius K, Molgaard A, Gupta R, Brunak S. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 2005, 15:153-164.
17. Fladeby C, Gupta SN, Barois N, Lorenzo PI, Simpson JC, Saatcioglu F, Bakke O. Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells. Int J Cancer 2008, 122:1229-1235.
18. Schonteich E, Wilson GM, Burden J, Hopkins CR, Anderson K, Goldenring JR, Prekeris R. The Rip11/Rab11-FIP5 and kinesin II complex regulates endocytic protein recycling. J Cell Sci 2008, 121:3824-3833. 10.1242/jcs.032441, 18957512.
19. Huth US, Schubert R, Peschka-Suss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J Control Release 2006, 110:490-504. 10.1016/j.jconrel.2005.10.018, 16387383.
20. Chambard JC, Lefloch R, Pouyssegur J, Lenormand P. ERK implication in cell cycle regulation. Biochim Biophys Acta 2007, 1773:1299-1310. 10.1016/j.bbamcr.2006.11.010, 17188374.
21. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2:489-501. 10.1038/nrc839, 12094235.
22. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007, 7:41-51. 10.1038/nri1995, 17186030.
23. Middelberg RP, Benyamin B, de Moor MH, Warrington NM, Gordon S, Henders AK, Medland SE, Nyholt DR, de Geus EJ, Hottenga JJ, et al. Loci affecting gamma-glutamyl transferase in adults and adolescents show age x SNP interaction and cardiometabolic disease associations. Hum Mol Genet 2012, 21:446-455. 10.1093/hmg/ddr478, 3276286, 22010049.
24. Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem 2011, 305:1-22. 10.1007/128_2011_157, 21528440.
25. Jeong BH, Lee KH, Lee YJ, Yun J, Park YJ, Cho HJ, Kim YH, Cho YS, Choi EK, Carp RI, Kim YS. Absence of association between two HECTD2 polymorphisms and sporadic Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2011, 31:146-151. 10.1159/000324133, 21335971.
26. Bruyninx M, Hennuy B, Cornet A, Houssa P, Daukandt M, Reiter E, Poncin J, Closset J, Hennen G. A novel gene overexpressed in the prostate of castrated rats: hormonal regulation, relationship to apoptosis and to acquired prostatic cell androgen independence. Endocrinology 1999, 140:4789-4799. 10.1210/en.140.10.4789, 10499539.
27. Cornet AM, Hanon E, Reiter ER, Bruyninx M, Nguyen VH, Hennuy BR, Hennen GP, Closset JL. Prostatic androgen repressed message-1 (PARM-1) may play a role in prostatic cell immortalisation. Prostate 2003, 56:220-230. 10.1002/pros.10254, 12772192.
28. Isodono K, Takahashi T, Imoto H, Nakanishi N, Ogata T, Asada S, Adachi A, Ueyama T, Oh H, Matsubara H. PARM-1 is an endoplasmic reticulum molecule involved in endoplasmic reticulum stress-induced apoptosis in rat cardiac myocytes. PLoS One 2010, 5:e9746. 10.1371/journal.pone.0009746, 2841187, 20305782.
29. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009, 9:874-885. 10.1038/nrc2761, 2951677, 19935676.
30. Santini D, Baldi A, Vincenzi B, Mellone P, Campioni M, Antinori A, Borzomati D, Coppola R, Magistrelli P, Tonini G. Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma. J Clin Pathol 2007, 60:1069-1070. 1972431, 17761747.
31. Efthimiopoulos S, Vassilacopoulou D, Ripellino JA, Tezapsidis N, Robakis NK. Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells. Proc Natl Acad Sci U S A 1996, 93:8046-8050. 10.1073/pnas.93.15.8046, 38872, 8755600.
32. Krog L, Olsen M, Dalseg AM, Roth J, Bock E. Characterization of soluble neural cell adhesion molecule in rat brain, CSF, and plasma. J Neurochem 1992, 59:838-847. 10.1111/j.1471-4159.1992.tb08321.x, 1494910.
33. Papa V, Russo P, Gliozzo B, Goldfine ID, Vigneri R, Pezzino V. An intact and functional soluble form of the insulin receptor is secreted by cultured cells. Endocrinology 1993, 133:1369-1376. 10.1210/en.133.3.1369, 8396017.
34. Mroczkowski B, Reich M, Chen K, Bell GI, Cohen S. Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Mol Cell Biol 1989, 9:2771-2778. 362742, 2789334.
35. Yee NS, Langen H, Besmer P. Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. J Biol Chem 1993, 268:14189-14201.
36. Yan R, Han P, Miao H, Greengard P, Xu H. The transmembrane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. J Biol Chem 2001, 276:36788-36796. 10.1074/jbc.M104350200, 11466313.
37. Wendler F, Tooze S. Syntaxin 6: the promiscuous behaviour of a SNARE protein. Traffic 2001, 2:606-611. 10.1034/j.1600-0854.2001.20903.x, 11555414.
38. Watson RT, Pessin JE. Functional cooperation of two independent targeting domains in syntaxin 6 is required for its efficient localization in the trans-golgi network of 3T3L1 adipocytes. J Biol Chem 2000, 275:1261-1268. 10.1074/jbc.275.2.1261, 10625671.
39. Matteoni R, Kreis TE. Translocation and clustering of endosomes and lysosomes depends on microtubules. J Cell Biol 1987, 105:1253-1265. 10.1083/jcb.105.3.1253, 2114818, 3308906.
40. Soldati T, Schliwa M. Powering membrane traffic in endocytosis and recycling. Nat Rev Mol Cell Biol 2006, 7:897-908. 10.1038/nrm2060, 17139330.
41. Kohlgraf KG, Gawron AJ, Higashi M, Meza JL, Burdick MD, Kitajima S, Kelly DL, Caffrey TC, Hollingsworth MA. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res 2003, 63:5011-5020.
42. Gonzalez FA, Raden DL, Davis RJ. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem 1991, 266:22159-22163.
43. Chung J, Uchida E, Grammer TC, Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 1997, 17:6508-6516. 232504, 9343414.
44. Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y, Chiba T. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene 2003, 22:548-554. 10.1038/sj.onc.1206109, 12555068.
45. Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007, 67:5699-5707. 10.1158/0008-5472.CAN-06-4478, 17575136.